The company offers a range of products including specialist antibodies, peptides, and recombinant proteins, as well as expertise in extracellular matrices to provide solutions for studying cell motility, migration, invasion, and proliferation. AMSBIO partners with clients in tailoring cell systems to enhance screening outcomes and eventual prognosis, and also provides molecular detection reagents, tissue DNA, RNA, protein, and microarray products for research in areas such as oncology, regenerative medicine, environmental analysis, cytotoxicity screening, glycomics, and stem cell biology.